Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Even with a successful cataract surgery, there are a variety of issues that can pop up postoperatively that can be problematic for patients, warranting further follow-up from the physician. Two physicians discussed some of the most common issues that they see following cataract surgery and how to address them.
How to break into refractive surgery as a young eye surgeon is the topic of the April YES Connect Webinar, and EyeWorld spoke with Dagny Zhu, MD, for her personal experience and insights ahead of the online event.
ASCRS Subspecialty Day will feature full-day programming in the areas of cornea, glaucoma, and refractive surgery. New this year, registrants of Subspecialty Day will also be able to attend the inaugural Digital Day program, taking place in conjunction with ASCRS Subspecialty Day and sponsored by the Digital Ophthalmic Society.
Karolinne Rocha, MD, PhD, introduces herself as the new Refractive Editor and previews the articles in the section.
➤ Positive preclinical results for non-viral gene therapy platform ➤ Real-world data confirms efficacy of investigational LHON therapy ➤ Largest genome wide study of photoreceptor cells to date ➤ CDC continues to investigate infectious outbreak associated with artificial tear use ➤ Updates from AAV-based gene therapy program for retinal conditions ➤ ASCRS news and events
Refractive Editor Vance Thompson, MD, shared his thoughts on the “hot topics” covered in the section and introduced the new Refractive Editor, Karolinne Rocha, MD, PhD.
Still a relatively new technology that is being incorporated into more devices, epithelial mapping use continues to become more widespread among refractive surgeons. From an availability standpoint, Dan Reinstein, MD, who pioneered mapping the epithelium, said “every OCT company is developing or has developed this functionality into their machines.”
The EVO Visian ICL (STAAR Surgical) was recently approved for the treatment of myopia and astigmatism, with updates to the previous ICL technology. Several physicians discussed the technology with EyeWorld: what’s new, how they’re using the product, and results they’ve seen so far.
Two surgeons shared how they have incorporated small incision lenticule extraction (SMILE) into practice, what they’ve learned, and issues that may occur. They also addressed advancements and future innovation in the space.
➤ FDA approves new therapy for amblyopia ➤ First-in-human data from IOL/drug-delivery platform ➤ Largest crosslinking study to date for keratoconus ➤ Interim data for Phase 2 trial evaluating choroidal melanoma treatment ➤ Gene therapy update ➤ SLT trial seeking more clinical sites, deadline October 14 ➤ Acquisition news ➤ ASCRS news and events